Pharmacokinetics of Some Synthetic Triazine Anticoccidials in Apparently Healthy North Island Brown Kiwi (Apteryx mantelli) Chicks
- PMID: 41376145
- DOI: 10.1111/jvp.70038
Pharmacokinetics of Some Synthetic Triazine Anticoccidials in Apparently Healthy North Island Brown Kiwi (Apteryx mantelli) Chicks
Abstract
Captive-reared kiwi (Apteryx spp.) chicks commonly suffer from coccidiosis, a parasitic disease that can cause morbidity and mortality in young immune-naive birds. Disease is currently managed in captivity through a combination of preventative husbandry practices and therapeutic treatment with the coccidiocide toltrazuril, for which no safety or pharmacokinetic data is available for kiwi. In this study we attempted to determine the pharmacokinetics of synthetic triazine anticoccidials, toltrazuril and diclazuril, in healthy three-to-four-week-old North Island brown kiwi (Apteryx mantelli) chicks. Birds were given a single oral dose of toltrazuril (25 mg/kg.bw; n = 6) or diclazuril (5 mg/kg.bw; n = 6), and closely monitored for adverse reactions. Serial blood samples were analysed via liquid chromatography-mass spectrometry (LC-MS) to determine the pharmacokinetics of both drugs, including the active metabolite of toltrazuril, toltrazuril sulphone. Pharmacokinetics were ascertained for both drugs in kiwi chicks. The mean (standard deviation) Cmax of diclazuril in plasma was 539.48 ± 169.63 ng/mL with a Tmax of 11.33 ± 1.63 h, while the Cmax for toltrazuril was 5622.16 ± 1997.52 ng/mL with a Tmax of 11.33 ± 1.63 h and Cmax of toltrazuril sulphone 3623.01 ± 1085.71 ng/mL with a Tmax of 96 ± 26.29 h. Mild changes to some biochemical parameters were observed, most notably elevations in uric acid in some toltrazuril-treated birds; however no remarkable clinical changes were observed in any chicks dosed with the drugs trialled.
Keywords: anticoccidial; drug safety; kiwi; pharmacokinetics; triazine.
© 2025 John Wiley & Sons Ltd.
References
-
- Abbas, R. Z., Z. Iqbal, D. Blake, M. N. Khan, and M. K. Saleemi. 2011. “Anticoccidial Drug Resistance in Fowl Coccidia: The State of Play Revisited.” World's Poultry Science Journal 67, no. 2: 337–349. https://doi.org/10.1017/S004393391100033X.
-
- Abd El Aziz, M., S. Abdel‐Motal, M. Khairy, et al. 1993. “Pharmacological Evaluation of Toltrazuril With Special Reference to Its Adverse Effects.” Zagazig Journal of Pharmaceutical Sciences 2, no. 2: 117–129. https://doi.org/10.21608/zjps.1993.187359.
-
- Abu‐Basha, E. A., R. Gehring, T. M. Hantash, A. F. Al‐Shunnaq, and N. M. Idkaidek. 2009. “Pharmacokinetics and Bioavailability of Sulfadiazine and Trimethoprim Following Intravenous, Intramuscular and Oral Administration in Ostriches (Struthio camelus).” Journal of Veterinary Pharmacology and Therapeutics 32, no. 3: 258–263. https://doi.org/10.1111/j.1365‐2885.2008.01036.x.
-
- Aktas, M., P. Vinclair, H. P. Lefebvre, P. L. Toutain, and J. P. Braun. 1995. “In Vivo Quantification of Muscle Damage in Dogs After Intramuscular Administration of Drugs.” British Veterinary Journal 151, no. 2: 189–196. https://doi.org/10.1016/S0007‐1935(95)80010‐7.
-
- Alwash, A. H., and P. C. Thomas. 1971. “The Effect of the Physical Form of the Diet and the Level of Feeding on the Digestion of Dried Grass by Sheep.” Journal of the Science of Food and Agriculture 22, no. 12: 611–615. https://doi.org/10.1002/jsfa.2740221203.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
